Concepedia

Jin Zhang

JZ

Statistics

Publications

34

Citations

9.1K

H-Index

21

Active since

2013

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

The University of Sydney

Sun Yat-sen University

Memorial Sloan Kettering Cancer Center

Jin Zhang is an author at Tianjin Medical University Cancer Institute and Hospital specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2013–2023

34

Publications

34

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Edward B. Garon, Naiyer A. Rizvi, Rina Hui et al. · New England Journal of Medicine · 2015 · 6.1K citations · Full text

A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis

Shicheng Su, Qiang Liu, Jingqi Chen et al. · Cancer Cell · 2014 · 775 citations · Full text

, , +11

Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma

Caroline Robert, Antoni Ribas, Omid Hamid et al. · Journal of Clinical Oncology · 2017 · 477 citations · Full text

, , +15

Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab

Richard W. Joseph, Jeroen Elassaiss‐Schaap, Richard Kefford et al. · Clinical Cancer Research · 2018 · 302 citations · Full text

Pembrolizumab (pembro) versus platinum-based chemotherapy (chemo) as first-line therapy for advanced/metastatic NSCLC with a PD-L1 tumor proportion score (TPS) ≥ 1%: Open-label, phase 3 KEYNOTE-042 study.

Gilberto Lopes, Yi‐Long Wu, Iveta Kudaba et al. · Journal of Clinical Oncology · 2018 · 192 citations

, , +14

1–5 of 34